COMBOPROFEN for Treatment of Muscular Pain Associated With Delayed Onset Muscle Soreness (DOMS)
Status:
Completed
Trial end date:
2017-11-28
Target enrollment:
Participant gender:
Summary
The study is designed as a proof of concept, single-center, randomized, double-blind, placebo
controlled study to assess the safety and efficacy of Comboprofen (Ibuprofen + Magnesium +
Vitamin C) compared to placebo, Ibuprofen, Magnesium and Vitamin C monotherapies in the
treatment of Delayed Onset Muscle Soreness (DOMS).
Phase:
Phase 2
Details
Lead Sponsor:
Spherium Biomed
Collaborator:
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau